T0	Limitation 23824 23829	Blood
T1	Limitation 23902 23906	This
T2	Limitation 24229 24237	Although
T3	Limitation 24732 24736	Only
T4	Limitation 24820 24832	Participants
T5	Limitation 25070 25072	It
T6	Limitation 25424 25427	The
T7	Limitation 30587 30589	As
T8	Limitation 26209 26211	We
T9	Limitation 25615 25618	The
T10	Limitation 29204 29208	This
T11	Limitation 28820 28827	Greater
T12	Limitation 30248 30250	In
T13	MissingData 23824 23900	Blood pressure at 12 months was not available for 28% of patients randomised
T14	HighLossToFollowUp 23917 23960	a high number of withdrawals from the study
T15	SampleSize 24238 24272	we did not achieve our sample size
T16	Population 24732 24818	Only 4% of patients on general practice stroke/TIA registers participated in the trial
T17	VerySpecificPopulation 24820 25068	Participants had a low prevalence of disability for a prevalent cerebrovascular disease population, were younger than typical patients in primary care with a history of cerebrovascular disease, and over-represented people with a history of TIA only
T18	VerySpecificPopulation 25165 25261	if the trial population was more representative of people with prevalent cerebrovascular disease
T19	StudyTeam 25424 25459	The outcome measure was not blinded
T20	ActivePlacebo 25615 25670	The standard target arm in PAST-BP was actively managed
T21	ActivePlacebo 26217 26234	an active control
T22	NonstandardTreatmentCharacteristics 29056 29108	greater reluctance of patients to increase treatment
T23	NonstandardTreatmentCharacteristics 28820 28879	Greater reluctance to lower blood pressure when near target
T24	HighLossToFollowUp 29261 29362	the significantly higher proportion of participants that withdrew from the trial in the intensive arm
T25	ActivePlacebo 30499 30534	he control arm was actively managed
T26	NonstandardTreatmentCharacteristics 30615 30747	reluctance on the part of both clinicians and patients to instigate all increases in blood pressure treatment in the intensive group
